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Abstract: 
A 49 year old female underwent multiple craniotomies for resection of aggressive meningeal tumours (WHO 
Grade III). She re-presented to hospital with sepsis due to ventriculitis. The craniotomy wound was urgently 
debrided and isolates of the Gram negative rod Weeksella virosa identified on 16S PCR. This species is most 
commonly found as a genitourinary commensal and here we report the first documented case of intracranial 
infection with this species and its successful treatment with a 6-week course of oral -lactam antibiotics. 
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A 49-year old, right handed female presented with early morning headaches and vomiting. Her past medical 
history was unremarkable. On examination, the only focal deficit elicited was a dense left homonymous 
hemianopia. Magnetic resonance imaging (MRI) of the brain revealed a lesion occupying the trigone and 
occipital horn of the right lateral ventricle (Figure 1A). No other intracranial lesions were seen, and computed 
tomography scans of the chest, abdomen and pelvis did not show any abnormalities. A complete macroscopic 
excision of the tumour was effected without problems. The postoperative MRI scan did not show any residual 
enhancing tumour tissue. The histology of the lesion was that of an atypical meningioma (WHO Grade II) with 
10 mitoses per 10 high power fields (10-HPF) and a Ki-67 nuclear labelling index (Ki67 NLI) of 23.1%. 
Given the high Ki-67 index, the patient was offered whole brain radiotherapy. The patient developed 
increasing headaches 8 months after surgery which responded to dexamethasone 4mg qid. Repeat MR 
scanning revealed a new right temporo-occipital tumour (Figure 1B). There was no obvious tumour recurrence 
at the site of the original operation. She underwent a second operation to remove the lesion which indicated 
that it was an anaplastic meningioma (WHO Grade III) with 22 mitoses per 10-HPF and a Ki67 NLI of 21.6%. 
Attempts to stop her steroids were unsuccessful as this resulted in a recurrence of her headaches. She had 
other scan 8-weeks after her second operation when her headaches intensified and she noted mild weakness 
in her left arm. The scans showed another tumour in the trigone of the right lateral ventricle. A third 
craniotomy was performed to resect this lesion, with post-operative imaging showing no residual enhancing 
tissue. Histological analysis confirmed a WHO Grade III meningioma with 26 mitoses per 10-HPF and a Ki67 
NPL of 68.8%. 
The patient recovered well after her third operation and was discharged 6-days later. Five days following 
discharge, she was re-admitted after becoming increasingly drowsy and weak on her left side. She was febrile 
(38.8C), difficult to rouse and had grade 0 power on her left side. There was no meningism but the surgical 
wound was boggy and warm. Her inflammatory markers were raised (C- reactive protein levels 275mg/l). 
Enhanced CT scans of her brain showed a subgaleal fluid collection, hydrocephalus and intraventricular 
sediment (Figure 1C). The patient promptly underwent debridement of the scalp wound, removal of bone 
flap, and drainage of extradural and ventricular empyema. External drains were placed in both ventricles to 
treat the hydrocephalus and to allow the egress of infected ventricular material. 
Cultures of intraventricular pus grew Weeksella virosa (sensitive to amoxicillin, co-amoxiclav, cephalosporins, 
piperacillin-tazobactam, meropenem, resistant to gentamicin and ciprofloxacin) which was confirmed on 16S 
rDNA PCR. Blood, urine and sputum cultures from the time of admission were bland. Based on the culture 
sensitivities, the patient was given 4-weeks of intravenous ceftriaxone 2g BD followed by 2-weeks of oral 
amoxicillin 500mg QDS. On this antibiotic regimen, her general condition rapidly improved and her 
inflammatory markers decreased to normal. An MRI scan undertaken 8-weeks after surgery (Figure 1D) 
showed residual oedema in the right basal ganglia but resolution her ventriculitis. The patient survived 




Weeksella virosa is an aerobic, non-pigmented, non-motile Gram negative rod. It is the sole member of the 
genus Weeksella, described originally in 1970[3] and named[1] in homage of O.B. Weeks’ work on the 
taxonomy of the family Flavobacterium. ‘Virosa’ (Latin for ‘slimy’) refers to the species’ cream-coloured 
mucoid colonies which grow on blood and chocolate agar after 48h incubation. Investigations into the source 
of Weeksella virosa in humans have shown that the bacterium displays a proclivity towards the urogenital 
tract. 72.3% of the strains isolated by Holmes et al. were from the urine or genital tract[1]; other sites included 
blood, umbilical area, rectal area, ears, eyes, mastoid and cerebrospinal fluid[1]. Indeed, in one of the first 
descriptions of the bacterium in a clinical context[4], it was originally designated as Flavibacterium genitale 
due to its preponderance for the urogenital tract. More recent studies have shown varying incidences of 
0.42%[5] to 15%[6] from this source. 
It is rare for Weeksella virosa to cause disease in humans; only 8 cases have been reported in the literature[6], 
causing clinical syndromes including spontaneous bacterial peritonitis, pneumonia and sepsis. Weeksella 
virosa has never been reported to have caused an intracranial infection, and this case represents the first such 
description. A group of Belgian cases of neonatal meningitis reported in 1958[8] were later found to be due to 
a Flavobacterium[2], although this is a separate species now known as Elizabethkingia meningoseptica. 
Owing in part to the dearth of clinical reports on pathogenic Weeksella virosa, there is a lack of high-quality 
evidence on the species’ antibiotic sensitivity. Success has been achieved with -lactam antibiotics[5, 6], and 
on the basis of such anecdotal reports our patient was treated empirically – and successfully – with 
ceftriaxone and amoxicillin. Aminoglycoside antibiotics should be avoided due to the intrinsic resistance of 
Weeksella virosa to this class of antibiotics[9]. 
The prevalence of nosocomial infection in the neurosurgical patient population in the UK has been estimated 
at 10.5%, and the rate of surgical site infection for craniotomy operations estimated at 3.3%[7]. Only in a 
proportion of the latter figure will there have been a concomitant ventriculitis, the true prevalence of which is 
difficult to estimate. Ventriculitis is a serious form of CNS infection, caused by microbial penetration and 
inflammation of the ependymal cell layer lining the ventricular cavities. In neurosurgical practice it is most 
commonly seen as a complication of EVD placement, in around 10.2%[10]. The overwhelming majority of 
causative microbes are Gram positive skin commensal bacteria (Staphylococcus aureus, Staphylococcus 
epidermidis, Propionibacterium acnes) in almost 80%. Far less common are Gram negative bacteria such as 
Klebsiella pneumonia, Haemophilus influenza, Pseudomonas aeruginosa. This is the first reported case of the 
Gram negative rod Weeksella virosa causing intracranial infection in humans. 
This patient had several risk factors for developing CNS infection: long-term use of steroids to control 
symptoms of cerebral oedema related to recurrent tumours; recent whole brain radiotherapy potentiating 
wound breakdown after repeated craniotomies; necessary breach of ependyma during intraventricular 
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microneurosurgery and breakdown of the blood-brain barrier creating a conduit for infection into the 
ventricles. Unfortunately, none of these factors were modifiable, but rather were contingent on her 
aggressive intracranial neoplastic disease. 
We here report the first documented case of Weeksella virosa causing intracranial infection in a human, in the 
setting of aggressive cerebral neoplastic disease, and its successful treatment using a combination of 
intravenous and oral -lactam antibiotics over a 6-week course. 
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Fig 1. a, T1+contrast MRI taken at index 
presentation showing the tumour within the 
trigone of the right lateral ventricle. b, T1+contrast 
MRI taken at time of first recurrence, 8 months 
later. Note that the recurrence was distant to the 
site of the original tumour. c, CT+contrast taken at 
time of presentation with sepsis syndrome. There 
was dilatation of the ventricles and fluid levels in 
both lateral ventricles. d, T1+contrast MRI taken 
three months after her third operation. There is no 
ventriculomegaly and some enhancing gliotic 
tissue at the site of previous surgrery. 
